Effect of genetic testing for risk of type 2 diabetes mellitus on health behaviors and outcomes: Study rationale, development and design

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Cho, Alex H ^a   Killeya Jones, Ley A ^b   O'Daniel, Julianne M ^c   Kawamoto, Kensaku ^d   Gallagher, Patrick ^e   Haga, Susanne ^f   Lucas, Joseph E ^f   Trujillo, Gloria M ^a   Joy, Scott V ^a   Ginsburg, Geoffrey S ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL   (United States)

^c ILLUMINA INC   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e DURHAM VA MEDICAL CENTER   (United States)

^f DUKE UNIVERSITY   (United States)

Author keywords

genetic information clinical utility; genetic testing; preventive health behavior; RCT protocol; risk perception; type 2 diabetes

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENETIC PREDISPOSITION; GENETIC SCREENING; GENETICS; HEALTH BEHAVIOR; HUMAN; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEALTH BEHAVIOR; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RESEARCH DESIGN; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84855878579     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-16     Document Type: Article

References (49)

1. Charting a course for genomic medicine from base pairs to bedside. Green ED, Guyer MS, Nature 2011 470 7333 204 213 10.1038/nature09764 21307933
2. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States. Prevention CfDCa, Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention 2011
3. Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization 2009
4. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Knowler WC, Fowler SE, Hamman RF, Christophi CA, Hoffman HJ, Brenneman AT, Brown-Friday JO, Goldberg R, Venditti E, Nathan DM, Lancet 2009 374 9702 1677 1686 10.1016/S0140-6736(09)61457-4 19878986
5. Facilitating treatment adherence with lifestyle changes in diabetes. Koenigsberg MR, Bartlett D, Cramer JS, Am Fam Physician 2004 69 2 309 316 14765768
6. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Disease Collaborating Group, Lancet 2011 377 9765 557 567 10.1016/S0140-6736(10)62037-5 21295846
7. The global obesity pandemic: shaped by global drivers and local environments. Swinburn BA, Sacks G, Hall KD, McPherson K, Finegood DT, Moodie ML, Gortmaker SL, Lancet 2011 378 9793 804 814 10.1016/S0140-6736(11)60813-1 21872749
8. Effectiveness of a comprehensive diabetes lower-extremity amputation prevention program in a predominantly low-income African-American population. Patout CA Jr, Birke JA, Horswell R, Williams D, Cerise FP, Diabetes Care 2000 23 9 1339 1342 10.2337/diacare.23.9.1339 10977029
9. Background and recruitment data for the U.S. Diabetes Prevention Program. Fujimoto WY, Diabetes Care 2000 23 Suppl 2 11 13 10860185
10. Genomics, type 2 diabetes, and obesity. McCarthy MI, N Engl J Med 2010 363 24 2339 2350 10.1056/NEJMra0906948 21142536
11. Genetic risk reclassification for type 2 diabetes by age below or above 50 years using 40 type 2 diabetes risk single nucleotide polymorphisms. de Miguel-Yanes JM, Shrader P, Pencina MJ, Fox CS, Manning AK, Grant RW, Dupuis J, Florez JC, D'Agostino RB, Cupples LA, Meigs JB, MAGIC Investigators, DIAGRAM+ Investigators, Diabetes Care 2011 34 1 121 125 10.2337/dc10-1265 20889853
12. Genetic risk profiling for prediction of type 2 diabetes. Mihaescu R, Meigs J, Sijbrands E, Janssens AC, PLoS Curr 2011 3 RN1208 21278902
13. Delivery of genomic medicine for common chronic adult diseases: a systematic review. Scheuner MT, Sieverding P, Shekelle PG, JAMA 2008 299 11 1320 1334 10.1001/jama.299.11.1320 18349093 (Pubitemid 351439078)
14. The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors? McBride CM, Koehly LM, Sanderson SC, Kaphingst KA, Annu Rev Public Health 2010 31 89 103 10.1146/annurev.publhealth.012809.103532 20070198
15. Effects of genetic counseling for hypertension on changes in lifestyle behaviors among African-American women. Taylor JY, Wu CY, J Natl Black Nurses Assoc 2009 20 1 1 10 20364720
16. How Does Pleiotropic Information Affect Health Behavior Changes? Initial Results from the REVEALStudy, a Randomized Trial of Genetic Testing for Alzheimer's Disease Risk [Abstract]. Christensen KD, Roberts JS, Uhlmann WR, Whitehouse PJ, Obisesan T, Bhatt DL, Green RC, American College of Medical Genetics Annual Meeting. March 2010. Available at http://submissions.miracd.com/ acmg/ContentInfo.aspx?conID = 1489. Accessed December 1, 2011
17. Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Marteau TM, Weinman J, Soc Sci Med 2006 62 6 1360 1368 10.1016/j.socscimed.2005.08.005 16162383 (Pubitemid 43204245)
18. Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Leventhal H, Diefenbach M, Leventhal EA, Cognitive Therapy and Research 1992 16 2 143 163 10.1007/BF01173486
19. Information processing in the context of genetic risk: implications for genetic-risk communication. Etchegary H, Perrier C, J Genet Couns 2007 16 4 419 432 10.1007/s10897-006-9082-z 17473961 (Pubitemid 47305502)
20. Lay constructions of a family history of heart disease: potential for misunderstandings in the clinical encounter? Hunt K, Emslie C, Watt G, Lancet 2001 357 9263 1168 1171 10.1016/S0140-6736(00)04334-8 11323044 (Pubitemid 32378689)
21. Genome pioneer Francis Collins looks within, loses weight. Szabo L, USA Today 2011
22. State Center for Health Statistics NDoHaHS, North Carolina Behavioral Risk Factor Surveillance Survey System (BRFSS) 2007
23. Association between TCF7L2 gene polymorphisms and susceptibility to type 2 diabetes mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. Tong Y, Lin Y, Zhang Y, Yang J, Liu H, Zhang B, BMC Med Genet 2009 10 15 19228405
24. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. Florez JC, Jablonski KA, Bayley N, Pollin TI, de Bakker PI, Shuldiner AR, Knowler WC, Nathan DM, Altshuler D, N Engl J Med 2006 355 3 241 250 10.1056/NEJMoa062418 16855264 (Pubitemid 44079339)
25. Family history of type 2 diabetes: a population-based screening tool for prevention? Hariri S, Yoon PW, Qureshi N, Valdez R, Scheuner MT, Khoury MJ, Genet Med 2006 8 2 102 108 10.1097/01.gim.0000200949.52795.df 16481893
26. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion. Wang J, Kuusisto J, Vanttinen M, Kuulasmaa T, Lindstrom J, Tuomilehto J, Uusitupa M, Laakso M, Diabetologia 2007 50 6 1192 1200 10.1007/s00125-007-0656-6 17437080 (Pubitemid 46701561)
27. After the diagnosis: The roles of genetic counseling. McConkie-Rosell A, O'Daniel JM, Neurogenetic Developmental Disorders: Manifestation and Identification in Childhood Cambridge, MA: MIT Press, JL MMR, 2007
28. AADE7 Self-Care Behaviors. American Association of Diabetes Educators, Available at: http://www.diabeteseducator.org/ProfessionalResources/AADE7/. Accessed November 1, 2010
29. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC, Diabetologia 1985 28 7 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
30. The homeostasis model in the San Antonio Heart Study. Haffner SM, Miettinen H, Stern MP, Diabetes Care 1997 20 7 1087 1092 10.2337/diacare.20.7. 1087 9203442 (Pubitemid 27274268)
31. 2000 National Health Interview Survey. Statistics NCfH, Public Health Service 2000
32. Development of the World Health Organization's Global Physical Activity Questionnaire (GPAQ). Armstrong TaB, Fiona, Journal of Public Health 2006 14 2 66 70 10.1007/s10389-006-0024-x
33. Body size and shape changes and the risk of diabetes in the diabetes prevention program. Fujimoto WY, Jablonski KA, Bray GA, Kriska A, Barrett-Connor E, Haffner S, Hanson R, Hill JO, Hubbard V, Stamm E, Pi-Sunyer FX, Diabetes Prevention Program Research Group, Diabetes 2007 56 6 1680 1685 10.2337/db07-0009 17363740 (Pubitemid 46842603)
34. The brief illness perception questionnaire. Broadbent E, Petrie KJ, Main J, Weinman J, J Psychosom Res 2006 60 6 631 637 10.1016/j.jpsychores.2005.10.020 16731240 (Pubitemid 43786439)
35. A brief assessment of concerns associated with genetic testing for cancer: the Multidimensional Impact of Cancer Risk Assessment (MICRA) questionnaire. Cella D, Hughes C, Peterman A, Chang CH, Peshkin BN, Schwartz MD, Wenzel L, Lemke A, Marcus AC, Lerman C, Health Psychol 2002 21 6 564 572 12433008 (Pubitemid 35244769)
36. Clinic-based support to help overweight patients with type 2 diabetes increase physical activity and lose weight. Christian JG, Bessesen DH, Byers TE, Christian KK, Goldstein MG, Bock BC, Arch Intern Med 2008 168 2 141 146 10.1001/archinternmed.2007.13 18227359 (Pubitemid 351185880)
37. Evaluation of a primary care-oriented brief counselling intervention for obesity with and without orlistat. Poston WS, Haddock CK, Pinkston MM, Pace P, Reeves RS, Karakoc N, Jones P, Foreyt JP, J Intern Med 2006 260 4 388 398 10.1111/j.1365-2796.2006.01702.x 16961676 (Pubitemid 44370912)
38. Effect of weight loss and nutritional intervention on arterial stiffness in type 2 diabetes. Barinas-Mitchell E, Kuller LH, Sutton-Tyrrell K, Hegazi R, Harper P, Mancino J, Kelley DE, Diabetes Care 2006 29 10 2218 2222 10.2337/dc06-0665 17003296 (Pubitemid 44899855)
39. Physical activity, dietary intake and metabolic risk factors in non-diabetic daughters of patients with type II diabetes. Higgins S, Gill JM, Janilionyte R, Caslake MJ, Malkova D, Prev Med 2005 40 2 145 151 10.1016/j.ypmed.2004.05.004 15533523 (Pubitemid 39468604)
40. Even low-intensity and low-volume exercise training may improve insulin resistance in the elderly. Kodama S, Shu M, Saito K, Murakami H, Tanaka K, Kuno S, Ajisaka R, Sone Y, Onitake F, Takahashi A, Shimano H, Kondo K, Yamada N, Sone H, Intern Med 2007 46 14 1071 1077 10.2169/internalmedicine.46.0096 17634702 (Pubitemid 47354461)
41. Sedentary lifestyle and antecedents of cardiovascular disease in young adults. McGavock JM, Anderson TJ, Lewanczuk RZ, Am J Hypertens 2006 19 7 701 707 10.1016/j.amjhyper.2006.01.013 16814124 (Pubitemid 43928522)
42. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Santaguida PL, Balion C, Hunt D, Morrison K, Gerstein H, Raina P, Booker L, Yazdi H, Evid Rep Technol Assess (Summ) 2005 128 1 11
43. Screening for type 2 diabetes mellitus in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008 148 11 846 854 18519930
44. Evaluating the utility of personal genomic information. Foster MW, Mulvihill JJ, Sharp RR, Genet Med 2009 11 8 570 574 10.1097/GIM.0b013e3181a2743e 19478683
45. Re-conceptualizing risk in genetic counseling: implications for clinical practice. Austin JC, J Genet Couns 2010 19 3 228 234 10.1007/s10897-010-9279-z 20119700
46. Prospect Theory-Analysis of Decision under Risk. Kahneman D, Tversky A, Econometrica 1979 47 2 263 291 10.2307/1914185
47. Prospect theory, reference points, and health decisions. Schwartz A, Goldberg J, Judgment and Decision Making 2008 3 2 174 180
48. Numeracy skill and the communication, comprehension, and use of risk-benefit information. Peters E, Hibbard J, Slovic P, Dieckmann N, Health Aff (Millwood) 2007 26 3 741 748 10.1377/hlthaff.26.3.741
49. Objective standards are not enough: affective, self-evaluative, and behavioral responses to social comparison information. Klein W, J Pers Soc Psychol 1997 72 763 774 9108694 (Pubitemid 127688817)